Search Results - "Simoons ML"

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.

Authors: Dagenais GR Pogue J Fox K et al.

Source: Lancet. 8/12/2006, Vol. 368 Issue 9535, p581-588. 8p.

Acute myocardial infarction.

Authors: Boersma E Mercado N Poldermans D et al.

Source: Lancet. 3/8/2003, Vol. 361 Issue 9360, p847-858. 12p.

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

Authors: Boersma E Maas ACP Deckers JW et al.

Source: Lancet. 9/21/1996, Vol. 348 Issue 9030, p771-775. 5p.

A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study.

Authors: Simoons ML Bobbink IWG Boland J et al.

Source: Journal of the American College of Cardiology (JACC). Jun2004, Vol. 43 Issue 12, p2183-2190. 8p.

A review of the long term effects of thrombolytic agents.

Authors: van Domburg RT Boersma E Simoons ML

Source: Drugs. Aug2000, Vol. 60 Issue 2, p293-305.

URL: 9592833

Obesity, cardiology, and beyond.

Authors: Simoons ML Bonneux L

Source: Journal of the American College of Cardiology (JACC). Sep2008, Vol. 52 Issue 12, p986-987. 2p.

Presidential address. A new journal for an old profession: to improve the quality of life of the European population by reducing the impact of cardiovascular disease.

Authors: Simoons ML (AUTHOR)

Source: European Journal of Cardiovascular Nursing. Feb2002, Vol. 1 Issue 1, p5-5. 1p.

Reliable assessment of sedation level in routine clinical practice by adding an instruction to the Ramsay Scale.

Authors: van Dishoeck A van der Hooft T Simoons ML et al.

Source: European Journal of Cardiovascular Nursing. Jun2009, Vol. 8 Issue 2, p125-128. 4p.

Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-I Trial)

Authors: Kandzari DE Granger CB Simoons ML et al.

Source: American Journal of Cardiology. Feb2004, Vol. 93 Issue 4, p458-461. 4p.

Clopidogrel and endothelial injury after percutaneous coronary interventions: beyond the antiplatelet effects.

Authors: Rudez G Duckers HJ Simoons ML

Source: Journal of the American College of Cardiology (JACC). Sep2010, Vol. 56 Issue 13, p1032-1033. 2p.

Third universal definition of myocardial infarction.

Authors: Thygesen K Alpert JS Jaffe AS et al.

Source: Nature Reviews Cardiology. Nov2012, Vol. 9 Issue 11, p620-633. 14p.

Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study).

Authors: Rodriguez-Granillo GA Vos J Bruining N et al.

Source: American Journal of Cardiology. Jul2007, Vol. 100 Issue 2, p159-163. 5p.

The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation.

Authors: Lenzen MJ Scholte op Reimer WJM Pedersen SS et al.

Source: Heart. Mar2007, Vol. 93 Issue 3, p339-344. 6p.

Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality Benefit From Coronary Revascularization in Acute Coronary Syndromes A GUSTO-IV Substudy.

Authors: James SK Lindbäck J Tilly J et al.

Source: Journal of the American College of Cardiology (JACC). Sep2006, Vol. 48 Issue 6, p1146-1154. 9p.

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)

Authors: James SK Lindahl B Timmer JR et al.

Source: American Journal of Cardiology. Jan2006, Vol. 97 Issue 2, p167-172. 6p.

Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.

Authors: Schinkel AFL Elhendy A Bax JJ et al.

Source: American Journal of Cardiology. Jan2006, Vol. 97 Issue 1, p1-6. 6p.

Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes.

Authors: Bhatt DL Chew DP Lincoff AM et al.

Source: American Journal of Cardiology. Jul2003, Vol. 92 Issue 2, p136-140. 5p.

Soluble CD40 ligand in acute coronary syndromes.

Authors: Heeschen C Dimmeler S Hamm CW et al.

Source: New England Journal of Medicine. 3/20/2003, Vol. 348 Issue 12, p1104-1111. 8p.

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Authors: Aviles RJ Askari AT Lindahl B et al.

Source: New England Journal of Medicine. 6/27/2002, Vol. 346 Issue 26, p2047-2052. 6p.

Contribution of nursing to risk factor management as perceived by patients with established coronary heart disease.

Authors: Scholte op Reimer WJM Jansen CH de Swart EAM et al.

Source: European Journal of Cardiovascular Nursing. Jun2002, Vol. 1 Issue 2, p87-94. 8p.